Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Income (Loss) per Share

v3.22.2.2
Basic and Diluted Net Income (Loss) per Share
 9 Months Ended
Sep. 30, 2022
Earnings Per Share [Abstract]  
Basic and Diluted Net Income (Loss) per Share Basic and Diluted Net Income (Loss) per Share
Basic net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding. Diluted net income (loss) per share is computed based on the weighted average number of shares of common stock outstanding, increased by the number of additional shares that would have been outstanding had the potentially dilutive shares of common stock been issued. The Company applies the treasury stock method to determine the dilutive effect of potentially dilutive securities.
The following table sets forth the computation of the Company’s basic and diluted net income (loss) per share attributable to common stockholders:
Three Months Ended September 30, Nine Months Ended September 30,
2022 2021 2022 2021
(In thousands, except share and per share data)
Numerator:
Net loss $ (75,195) $ (66,578) $ (12,587) $ (92,663)
Denominator:
Basic weighted average shares outstanding 185,560,177  19,793,863  184,454,371  17,348,557 
Diluted weighted average shares outstanding 185,560,177  19,793,863  184,454,371  17,348,557 
Net loss per share
     Basic $ (0.41) $ (3.36) $ (0.07) $ (5.34)
     Diluted $ (0.41) $ (3.36) $ (0.07) $ (5.34)
The following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation of diluted net income (loss) per share attributable to common stockholders as including them would have had an antidilutive effect:
Three Months Ended September 30, Nine Months Ended
September 30,
2022 2021 2022 2021
Common stock warrants 13,145,000  13,075,000  13,145,000  13,075,000 
Restricted stock units 6,198,472  —  6,198,472 
Common stock options 17,731,063  21,342,660  17,731,063  21,342,660 
Total potentially dilutive common share equivalents 37,074,535  34,417,660  37,074,535  34,417,660 
Total potentially dilutive common share equivalents for the three and nine months ended September 30, 2022 and September 30, 2021 excludes 21,758,148 shares related to the earnout liability as these shares are contingently issuable upon meeting certain triggering events.